Please provide your email address to receive an email when new articles are posted on . Roy Rubinfeld and I share a unique connection. I first visited him at his office in Washington, D.C., in 2008.
An epithelium-off corneal cross-linking treatment has been approved in the U.S. for nearly a decade.During that time, we have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results